Published July 14, 2022
| Version v1
Dataset
Open
Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy
Authors/Creators
Authors/Creators
- 1. University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, D-40225 Dusseldorf, Germany
- 2. University Dusseldorf, Medical Faculty, Department of Urology, D-40225 Dusseldorf, Germany
- 3. University Dusseldorf, Medical Faculty, Department of Pathology, D-40225 Dusseldorf, Germany
Description
This is a dataset from the original publication “Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsy”. From 01/2014 to 04/2019 a sample collective of 785 patients with 3T multiparametric magnetic resonance imaging (mp-MRI) of the prostate and subsequent combined systematic biopsy (SB) and magnetic resonance imaging/ultrasound (US) fusion-guided biopsy (TB) was retrospectively analyzed. Prostate carcinoma (PCa) detection by TB and/or additional SB was analyzed.
Notes
Related research article:
Klingebiel M., Arsov C., Ullrich T., Quentin M., Al-Monajjed R., Mally D., Sawicki L.M., Hiester A., Esposito I., Albers P., Antoch G., Schimmöller L., Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsy, Eur J Radiol. 2021 Apr;137:109587. DOI: 10.1016/j.ejrad.2021.109587
Files
Files
(278.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:77477c5f980ac9ccaa80caa2f3c7c3ac
|
278.5 kB | Download |
Additional details
Related works
- Is supplement to
- Journal article: 10.1016/j.ejrad.2021.109587 (DOI)